Chang Ho Ahn - Net Worth and Insider Trading
Chang Ho Ahn Net Worth
The estimated net worth of Chang Ho Ahn is at least $98,189 dollars as of 2024-09-20. Chang Ho Ahn is the Director of Rexahn Pharmaceuticals Inc and owns about 13,562 shares of Rexahn Pharmaceuticals Inc (REXN) stock worth over $98,189. Details can be seen in Chang Ho Ahn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chang Ho Ahn has not made any transactions after 2017-04-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chang Ho Ahn
Chang Ho Ahn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chang Ho Ahn owns 2 companies in total, including Rexahn Pharmaceuticals Inc (REXN) , and Ocuphire Pharma Inc (OCUP) .
Click here to see the complete history of Chang Ho Ahn’s form 4 insider trades.
Insider Ownership Summary of Chang Ho Ahn
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
REXN | Rexahn Pharmaceuticals Inc | 2017-04-10 | director |
OCUP | Ocuphire Pharma Inc | 2005-05-13 | director & 10 percent owner & Chief Executive Officer |
Chang Ho Ahn Latest Holdings Summary
Chang Ho Ahn currently owns a total of 1 stock. Chang Ho Ahn owns 13,562 shares of Rexahn Pharmaceuticals Inc (REXN) as of April 10, 2017, with a value of $98,189.
Latest Holdings of Chang Ho Ahn
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
REXN | Rexahn Pharmaceuticals Inc | 2017-04-10 | 13,562 | 7.24 | 98,189 |
Holding Weightings of Chang Ho Ahn
Chang Ho Ahn Form 4 Trading Tracker
According to the SEC Form 4 filings, Chang Ho Ahn has made a total of 0 transactions in Rexahn Pharmaceuticals Inc (REXN) over the past 5 years. The most-recent trade in Rexahn Pharmaceuticals Inc is the sale of 521 shares on April 10, 2017, which brought Chang Ho Ahn around $175,000.
Insider Trading History of Chang Ho Ahn
- 1
Chang Ho Ahn Trading Performance
GuruFocus tracks the stock performance after each of Chang Ho Ahn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chang Ho Ahn is -1.94%. GuruFocus also compares Chang Ho Ahn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chang Ho Ahn within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chang Ho Ahn's insider trading performs compared to the benchmark.
Performance of Chang Ho Ahn
Chang Ho Ahn Ownership Network
Chang Ho Ahn Owned Company Details
What does Rexahn Pharmaceuticals Inc do?
Who are the key executives at Rexahn Pharmaceuticals Inc?
Chang Ho Ahn is the director of Rexahn Pharmaceuticals Inc. Other key executives at Rexahn Pharmaceuticals Inc include Chief Medical Officer Ely Benaim , Chief Business Officer Lisa Nolan , and director & President and CEO Douglas J Swirsky .
Rexahn Pharmaceuticals Inc (REXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc (REXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc (REXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rexahn Pharmaceuticals Inc (REXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rexahn Pharmaceuticals Inc Insider Transactions
Chang Ho Ahn Mailing Address
Above is the net worth, insider trading, and ownership report for Chang Ho Ahn. You might contact Chang Ho Ahn via mailing address: 9620 Medical Center Drive, Rockville Md 20850.